- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
ReproCELL
Market Cap: JP¥15.2b
Provides stem cell research and drug discovery services in Japan.
4978
JP¥161.00
7D
-5.3%
1Y
25.8%
Mochida Pharmaceutical
Market Cap: JP¥105.3b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥2,969.00
7D
1.6%
1Y
0.6%
KYORIN Pharmaceutical
Market Cap: JP¥84.4b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,470.00
7D
0.5%
1Y
-14.3%
Zeria Pharmaceutical
Market Cap: JP¥96.0b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,177.00
7D
3.0%
1Y
11.7%
Kaken Pharmaceutical
Market Cap: JP¥144.3b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,811.00
7D
2.0%
1Y
4.0%